Cargando…
Correction: PPARγ sumoylation-mediated lipid accumulation in lung cancer
Autores principales: | Phan, Ai N.H., Vo, Vu T.A., Hua, Tuyen N.M., Kim, Min-Kyu, Jo, Se-Young, Choi, Jong-Whan, Kim, Hyun-Won, Son, Jaekyoung, Suh, Young-Ah, Jeong, Yangsik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6402714/ https://www.ncbi.nlm.nih.gov/pubmed/30858930 http://dx.doi.org/10.18632/oncotarget.26710 |
Ejemplares similares
-
PPARγ sumoylation-mediated lipid accumulation in lung cancer
por: Phan, Ai N.H., et al.
Publicado: (2017) -
Inhibition of oncogenic Src induces FABP4-mediated lipolysis via PPARγ activation exerting cancer growth suppression
por: Hua, Tuyen N.M., et al.
Publicado: (2019) -
Gallic acid inhibition of Src-Stat3 signaling overcomes acquired resistance to EGF receptor tyrosine kinase inhibitors in advanced non-small cell lung cancer
por: Phan, Ai N.H., et al.
Publicado: (2016) -
Iron commensalism of mesenchymal glioblastoma promotes ferroptosis susceptibility upon dopamine treatment
por: Vo, Vu T. A., et al.
Publicado: (2022) -
PPARγ-K107 SUMOylation regulates insulin sensitivity but not adiposity in mice
por: Katafuchi, Takeshi, et al.
Publicado: (2018)